Keyword
Quick search:
Result Content Outlet Published Research
Result Content Outlet Published Research
1 Regeneron Pharmaceuticals Inc. stock rises Tuesday, still underperforms market MarketWatch 9 hours ago
2 Pfizer Inc. stock rises Tuesday, still underperforms market MarketWatch 9 hours ago
3 TherapeuticsMD Inc. stock falls Tuesday, underperforms market MarketWatch 8 hours ago
4 Cooper Cos. stock rises Tuesday, outperforms market MarketWatch 9 hours ago
5 Incyte Corp. stock rises Tuesday, still underperforms market MarketWatch 9 hours ago
6 Incyte Corp. stock falls Monday, underperforms market MarketWatch 1 day ago
7 Regeneron Pharmaceuticals Inc. stock falls Monday, underperforms market MarketWatch 8 days ago
8 Incyte Corp. stock outperforms market on strong trading day MarketWatch 5 days ago
9 Regeneron Pharmaceuticals Inc. stock rises Wednesday, still underperforms market MarketWatch 14 days ago
10 Regeneron Pharmaceuticals Inc. stock falls Friday, still outperforms market MarketWatch 19 days ago
11 Regeneron Pharmaceuticals Inc. stock outperforms market despite losses on the day MarketWatch 26 days ago
12 Pfizer Inc. stock rises Friday, outperforms market MarketWatch 12 days ago
13 Regeneron Pharmaceuticals Inc. stock rises Monday, still underperforms market MarketWatch 23 days ago
14 TherapeuticsMD Inc. stock underperforms Friday when compared to competitors MarketWatch 12 days ago
15 Regeneron Pharmaceuticals Inc. stock rises Thursday, still underperforms market MarketWatch 20 days ago
16 TherapeuticsMD Inc. stock falls Thursday, underperforms market MarketWatch 13 days ago
17 Pfizer Inc. stock outperforms market despite losses on the day MarketWatch 19 days ago
18 ADRs End Lower; Chinese Companies Traded Actively MarketWatch 13 days ago
19 Pfizer Inc. stock rises Wednesday, outperforms market MarketWatch 21 days ago
20 TherapeuticsMD Inc. stock underperforms Wednesday when compared to competitors MarketWatch 21 days ago
21 Incyte Corp. stock outperforms market despite losses on the day MarketWatch 19 days ago
22 TherapeuticsMD Inc. stock underperforms Thursday when compared to competitors MarketWatch 20 days ago
23 TherapeuticsMD Inc. stock falls Wednesday, still outperforms market MarketWatch 28 days ago
24 NVS (Novartis AG ADR) Morningstar 22 days ago
25 Cooper Cos. stock outperforms market on strong trading day MarketWatch 23 days ago
26 Cooper Cos. stock outperforms competitors on strong trading day MarketWatch 28 days ago
27 Pharmacovigilance Global Market To Grow At Rate Of 12% Through 2026 EIN News 16 hours ago
28 Novartis: Exceedingly Stable Swiss Pharma Seeking Alpha 2 months ago
29 Novartis shareholders approve all resolutions proposed by the Board of Directors at the Annual General Meeting Novartis 2 months ago
30 Novartis announces new organizational structure to accelerate growth, strengthen pipeline and increase productivity Novartis 1 month ago
31 Novartis condemns the war in Ukraine and commits to supporting humanitarian efforts Novartis 2 months ago
32 Tracking Ken Fisher's Fisher Asset Management Portfolio Q1 2022 Update 11 days ago
33 ADRs End Lower; Baidu, Novartis Trade Actively MarketWatch 1 month ago
34 Novartis Stock: Sandoz Future Uncertain As Fourth Quarter Lags Investor's Business Daily 3 months ago
35 Novartis Is One Of The Best High-Yield Dividend Aristocrats You Can Buy In 2022 Seeking Alpha 3 months ago
36 Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases Novartis 2 months ago
37 Novartis condemns the war in Ukraine update March 22 2 months ago
38 FDA approves Novartis Vijoice® (alpelisib) as first and only treatment for select patients with PIK3CA-Related Overgrowth Spectrum (PROS) Novartis 1 month ago
39 Victor Bulto Novartis 1 month ago
40 Sandoz targets growth opportunities in respiratory and complex generics through acquisition of respiratory device company Coalesce Novartis 2 months ago
41 Global Biotech Cooperations Novartis 22 days ago
42 Novartis signs initial agreement with Carisma Therapeutics for the manufacturing of HER 2 targeted CAR-M cell therapy Novartis 2 months ago
43 Novartis announces European Commission approval of Beovu® for people living with diabetic macular edema Novartis 2 months ago
44 Daniel Hochstrasser Novartis 2 months ago
45 Novartis peer-reviewed safety and tolerability data further strengthens Kesimpta's (ofatumumab) favorable benefit-risk profile in patients with relapsing multiple sclerosis Novartis 3 months ago
46 Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection Novartis 2 months ago
47 Novartis Pluvicto™ approved by FDA as first targeted radioligand therapy for treatment of progressive, PSMA positive metastatic castration-resistant prostate cancer Novartis 2 months ago
48 Novartis presents new four-year data on efficacy and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis Novartis 1 month ago
49 Novartis receives positive CHMP opinion for Jakavi® to treat acute and chronic graft-versus-host disease Novartis 2 months ago
50 Sandoz launches generic lenalidomide in 19 countries across Europe, expanding access to essential oncology medicine Novartis 3 months ago
51 Novartis expands Zolgensma manufacturing capacity with approval of multi-product North Carolina facility Novartis 1 month ago
52 NEJM publication of Novartis Kisqali® data shows longest median overall survival ever reported in HR+/HER2- advanced breast cancer Novartis 2 months ago
53 Careers in Manufacturing and Supply Novartis 22 days ago
54 New peer-reviewed research shows no increased risk of serious COVID-19 infections in Kesimpta® (ofatumumab)-treated adults with multiple sclerosis Novartis 2 months ago
55 Novartis announces early clinical data for unique KRASG12C inhibitor at American Association for Cancer Research annual meeting Novartis 1 month ago
56 Sandoz launches generic brimonidine tartrate/timolol maleate eyedrop in US for patients with ocular hypertension, expanding leading ophthalmic portfolio Novartis 1 month ago
57 Novartis announces anti-PD-1 tislelizumab accepted by EMA for regulatory review in esophageal and lung cancers Novartis 1 month ago
58 Regeneron Pharmaceuticals Inc. stock rises Friday, outperforms market MarketWatch 1 month ago
59 Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day MarketWatch 2 months ago
60 Regeneron Pharmaceuticals Inc. stock rises Friday, still underperforms market MarketWatch 2 months ago
61 Pfizer Inc. stock falls Monday, underperforms market MarketWatch 1 month ago
62 Pfizer Inc. stock falls Tuesday, underperforms market MarketWatch 2 months ago
63 Pfizer Inc. stock underperforms Wednesday when compared to competitors MarketWatch 1 month ago
64 Shareholder Information Novartis 7 years ago
65 Regeneron Pharmaceuticals Inc. stock outperforms market on strong trading day MarketWatch 2 months ago
66 Incyte Corp. stock outperforms competitors on strong trading day MarketWatch 1 month ago
67 Cooper Cos. stock falls Monday, underperforms market MarketWatch 1 month ago
68 Incyte Corp. stock rises Monday, outperforms market MarketWatch 2 months ago
69 Pfizer Inc. stock underperforms Tuesday when compared to competitors MarketWatch 3 months ago
70 Cooper Cos. stock falls Thursday, underperforms market MarketWatch 1 month ago
71 Pfizer Inc. stock underperforms Thursday when compared to competitors MarketWatch 3 months ago
72 Incyte Corp. stock falls Wednesday, still outperforms market MarketWatch 3 months ago
73 Incyte Corp. stock rises Tuesday, outperforms market MarketWatch 4 months ago
74 Novartis data highlight efficacy of Piqray® in HR+/HER2- metastatic breast cancer with a PIK3CA driver mutation immediately post-CDK4/6i GlobeNewswire 5 months ago
75 Environmental sustainability Novartis 7 months ago
76 Stocks Generating Improved Relative Strength: Novartis Investor's Business Daily 1 month ago
77 Can Novartis AG (NVS) Stock Rise to the Top of Healthcare Sector Wednesday? InvestorsObserver 6 days ago
78 Validea Peter Lynch Strategy Daily Upgrade Report 2/3/2022 3 months ago
79 Which companies are leading the way for artificial intelligence in the pharma sector? Pharmaceutical Technology 10 months ago
80 Dr Reddy's to acquire Novartis' cardiovascular brand Cidmus in India Indiainfoline 1 month ago
81 Event Calendar Novartis 7 years ago
82 Novartis spins off Alcon unit MarketWatch 3 years ago
83 Share information Roche 3 months ago
84 Deciphera (DCPH) Q4 Loss Wider Than Expected, Revenues Beat Nasdaq 3 months ago
85 BioNTech to Boost Staff by 50% at Biggest German Vaccine Factory Bloomberg 4 months ago
86 Zarxio, Novartis AG (ADR) (NYSE:NVS) Biosimilar Drug Gets Approved by FDA Stocks.org 7 years ago
87 Ex-Head of Family Office for $31 Billion Fortune Builds Firm Bloomberg 4 months ago
88 Novartis: A Safer Way To Invest In Biotech While Collecting Lots Of Dividends Too Seeking Alpha 6 years ago